Cala Health, Inc.

Foundry Innovation & Research 1, Ltd.

Vijaykumar Rajasekhar

Kathryn H Rosenbluth

Scott Delp

John Eric Paderi

Tahel Altman

Hanson S Gifford, Iii

Mark E Deem

Douglas S Sutton

John H Morriss

Martin L Mayse

Jeffry J Grainger

Samuel Richard Hamner

Erika Kristine Ross

Hanson S Iii Gifford

A peripheral nerve stimulator to stimulate a peripheral nerve to treat essential tremor and other movement disorders, as well as overactive bladder, cardiac dysfunction and neurotransmitter dysfunction is provided. The peripheral nerve stimulator can be a noninvasive surface stimulator to provide multi-modal optimized therapy. Stimulation can be vibrational, electromechanical, thermal, radiant, electrical, magnetic, electromagnetic, light, mechanical, chemical, thermal, ultrasonic, radiofrequency (RF), acoustic, infrared, ultraviolet, x-ray, and/or microwave. Stimulation can be delivered using an open loop system and/or a closed loop system with feedback. Stimulation can be to one site or multiple sites.

Multi-modal stimulation for treating tremor

A peripheral nerve stimulator can be used to stimulate a peripheral nerve to treat essential tremor, Parkinson tremor, and other forms of tremor. The peripheral nerve stimulator can be either a noninvasive surface stimulator or an implanted stimulator. Stimulation can be electrical, mechanical, or chemical. Stimulation can be delivered using either an open loop system or a closed loop system with feedback.

Devices and methods for controlling tremor

Catheter-based devices and methods for continuously monitoring vascular lumen dimensions, in particular in the inferior vena cava (IVC) for determining heart failure and/or fluid status of a patient. Related therapy systems and methods for integrated monitoring and therapy are also disclosed.

Devices and methods for measurement of Vena Cava dimensions, pressure and oxygen saturation

Implantable devices for continuously monitoring vascular lumen dimensions, in particular in the inferior vena cava (IVC) for determining heart failure status of a patient. Related therapy systems as well as monitoring and therapy methods are also disclosed. Devices include active or passive marker elements placed in contact with, adhered to or injected into the vessel wall to generate or reflect signals from which lumen diameter may be determined. Disclosed devices may be fully implantable and self-contained including capabilities for wirelessly communication monitored parameters.

Implantable devices and related methods for heart failure monitoring

Growing community of inventors

San Francisco, CA, United States of America

Vijaykumar Rajasekhar